[Treatment of maniacal syndromes by dihydrogenated alkaloids of ergot of rye (hydergine) associated with electroshock].
D000470:Alkaloids; D001714:Bipolar Disorder; D002967:Claviceps; D004565:Electroconvulsive Therapy; D004597:Electroshock; D004877:Ergoloid Mesylates; D004874:Ergonovine; D004876:Ergot Alkaloids / Q000627:therapeutic use*; D011618:Psychotic Disorders / Q000628:therapy*; D012434:Secale; D013577:Syndrome
D000470:Alkaloids; D004876:Ergot Alkaloids; D004877:Ergoloid Mesylates; D004874:Ergonovine
ERGOT ALKALOIDS/therapeutic use; PSYCHOSES/therapy; SHOCK THERAPY, ELECTRIC
Traitement des syndromes maniaques par les alcaloïdes dihydrogènes de l'ergot de seigle (hydergine) associés aux électro-chocs.